Find and Pitch Jounalists, Get Your Story Covered

Tags: Samsung Biologics Kurma Partners biologics AI in biology , artificial intelligence, biochemistry, cell biology, morphology, protein folding, protein synthesis Structural biology

	Profile	Recent Articles on Subject
1	Fran Gregory Pharmacy Times	Expert Discusses Anticipated Trends in Biosimilar Market for 2024 - 5 months ago Expert Reflects on Trends, US Market of Biosimilars in 2023 - 5 months ago
2	Pharmaceutical Executive Editorial Staff Pharmaceutical Executive Pharma Executive Magazine. London & New Jersey PharmaceuticalsHealthcare	FDA Accepts Biologics License Application for CSL Behring’s Garadacimab for Hereditary Angioedema - 5 months ago FDA Grants Priority Review to Expand Indication for Bristol Myers Squibb’s Breyanzi in CLL, SLL - 6 months ago
3	Damian Garde STAT News Biotech reporter at STAT. Open to messages. biotechnologyjournalism	STAT+: 3 trends to watch in biotech in 2024 - 5 months ago Cell and gene therapies could be a safer bet than other drugs - 7 months ago
4	Ashley Gallagher, Associate Editor Pharmacy Times One of Cabra girls on GoggleboxIRL. Dublin City, Ireland televisionentertainment	FDA Grants Priority Review to New Biologics License Application for V116 Against Pneumococcal Disease - 5 months ago Study: IL-23 Inhibitors Associated With Lowest Risk of Paradoxical Eczema in Patients With Plaque Psoriasis - 5 months ago FDA Accepts Supplemental Biologics License Application for Hadlima for Interchangeability With Humira - 6 months ago Expert: Improving Efficiency of Biosimilar Operations, Advancing Interchangeable Biosimilar Development Among Top Priorities for FDA - 7 months ago Key Market Trends for the Current Specialty Drug Pipeline - 7 months ago Study: No Difference Found in Safety of Reference Biologic, Biosimilar - 7 months ago
5	Robert Mancini, PharmD Pharmacy Times	Bispecific Antibodies in DLBCL: Therapeutic Potential - 5 months ago
6	Emily Mullin Wired Staff writer at WIRED. Covers biotechnology. Fall 2021 fellow. Pittsburgh, Pennsylvania biotechnology	In a World First, a Patient's Antibody Cells Were Just Genetically Engineered - 5 months ago
7	Diana Swift MedPage Today	Clinical Challenges: Finding New Targets in Crohn's Disease Beyond Anti-TNF - 5 months ago
8	Monica Holmberg, PharmD, BCPS Pharmacy Times	Litfulo From Pfizer Inc - 5 months ago
9	Kelly Bilodeau Pharma Voice Mom, wife, freelance writer. writing	Oncology drugmakers seek the sweet spot between efficacy and tolerability - 5 months ago Biohaven wants to muscle in on the Ozempic craze with a competing class of drugs - 6 months ago An ‘inverse vaccine’ takes aim at autoimmune diseases - 7 months ago
10	Aislinn Antrim, Assistant Managing Editor Pharmacy Times Journalist at Pharmacy Times. UNC graduate. PoliticsStorytellingCats	The Future of Immunotherapy in Breast Cancer Involves Engineered T-Cell Therapies, Better Prediction of Adverse Effects - 5 months ago New Capivasertib Approval Benefits Patients With Breast Cancer, PIK3CA/AKT1/PTEN Alterations - 5 months ago

Journalists covering biologics